Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Finding Study”

1,766 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,766 results

Testing effectiveness (Phase 2)Study completedNCT03227224
What this trial is testing

Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 287
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Not applicableStudy completedNCT00410488
What this trial is testing

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

Who this might be right for
SarcomaNauseaVomiting
M.D. Anderson Cancer Center 51
Early research (Phase 1)Study completedNCT01755390
What this trial is testing

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Sanofi 42
Testing effectiveness (Phase 2)Study completedNCT02129673
What this trial is testing

A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open Angle GlaucomaOcular Hypertension
ViSci Ltd. 77
Testing effectiveness (Phase 2)Looking for participantsNCT04752774
What this trial is testing

Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.

Who this might be right for
Spasticity
Ipsen 240
Not applicableStudy completedNCT00512070
What this trial is testing

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Seattle Institute for Biomedical and Clinical Research 40
Testing effectiveness (Phase 2)Ended earlyNCT00878501
What this trial is testing

Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee

Who this might be right for
Pain
AstraZeneca 241
Early research (Phase 1)Study completedNCT02738970
What this trial is testing

A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 88
Testing effectiveness (Phase 2)Ended earlyNCT05838742
What this trial is testing

A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Who this might be right for
PainOsteoarthritis, Knee
GlaxoSmithKline 314
Early research (Phase 1)Study completedNCT01748019
What this trial is testing

ST1968 Intravenous (Weekly) in Solid Tumors

Who this might be right for
Solid Tumors
sigma-tau i.f.r. S.p.A. 62
Testing effectiveness (Phase 2)Looking for participantsNCT06782373
What this trial is testing

Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

Who this might be right for
VEXASVEXAS Syndrome
Swedish Orphan Biovitrum 78
Testing effectiveness (Phase 2)Study completedNCT03054337
What this trial is testing

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
AnemiaNon-dialysis Dependent Chronic Kidney Disease
Akebia Therapeutics 51
Testing effectiveness (Phase 2)Ended earlyNCT06142383
What this trial is testing

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT01653912
What this trial is testing

Dose-finding Study in Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum-resistant Ovarian Cancer
Accenture 59
Testing effectiveness (Phase 2)Ended earlyNCT00744341
What this trial is testing

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure

Who this might be right for
Acute Decompensated Heart Failure; Renal Dysfunction
Solvay Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT06662539
What this trial is testing

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

Who this might be right for
Obesity
Zealand Pharma 493
Testing effectiveness (Phase 2)Study completedNCT04307186
What this trial is testing

Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

Who this might be right for
Central Nervous System Pathology
Bayer 57
Large-scale testing (Phase 3)UnknownNCT03805282
What this trial is testing

Intravenous Lidocaine to Supress of Cough Reflex During Anesthesia Emergence

Who this might be right for
Cough
Brasilia University Hospital 132
Testing effectiveness (Phase 2)Ended earlyNCT00699842
What this trial is testing

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Who this might be right for
Myelodysplastic SyndromeMDSLow to Intermediate-1 MDS+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Load More Results